Article

Dr. Niteesh Choudhry Discusses Value-Based Insurance Design [Part 4 of 4]

Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, talks about the overwhelmingly positive feedback he has received from his colleagues about the significance of VBID, even when factoring in the suggested limitations from the myocardial infarction study.

In this segment, Dr. Choudhry discusses how the rigorous research methods that were applied in this VBID study proved valuable in several ways that transcends cost, such as highlighting the magnitude of nonadherence, and the need for physicians to understand that their work isn’t done once they’ve made the decision to prescribe.

Related Videos
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
Dr Gerard Criner
Emma Achola-Kothari, PhD
Dr Margrit Wiesendanger
Dr Emma Achola-Kothani
Marla Black Morgan, MD, Phoebe Neurology Associates
Christine Funke, MD
Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo